Assignee
CELL PATHWAYS INC
US·73 granted patents·1,789 citations·filing 1994–2002
Top patents by PatentIndex Score
73 records- 0196US6348032B1Method of inhibiting neoplastic cells with benzimidazole derivativesCELL PATHWAYS INC·Filed 1998·Granted Feb 19, 2002·117 cites·2 claims
- 0294US6046206AMethod of treating a patient having a precancerous lesions with amide quinazoline derivativesCELL PATHWAYS INC·Filed 1997·Granted Apr 4, 2000·150 cites·10 claims
- 0393US5948911AMethod for inhibiting neoplastic cells and related conditions by exposure to thienopyrimidine derivativesCELL PATHWAYS INC·Filed 1998·Granted Sep 7, 1999·69 cites·19 claims
- 0492US6358992B1Method of inhibiting neoplastic cells with indole derivativesCELL PATHWAYS INC·Filed 1999·Granted Mar 19, 2002·125 cites·14 claims
- 0592US6200980B1Method of treating a patient having precancerous lesions with phenyl purinone derivativesCELL PATHWAYS INC·Filed 1997·Granted Mar 13, 2001·60 cites·8 claims
- 0691US6380206B1Method of inhibiting neoplastic cells with 4,5-diaminopyrimidine derivativesCELL PATHWAYS INC·Filed 2001·Granted Apr 30, 2002·35 cites·6 claims
- 0791US6133271AMethod for inhibiting neoplastic cells and related conditions by exposure thienopyrimidine derivativesCELL PATHWAYS INC·Filed 1998·Granted Oct 17, 2000·92 cites·12 claims
- 0890US6369092B1Method for treating neoplasia by exposure to substituted benzimidazole derivativesCELL PATHWAYS INC·Filed 2001·Granted Apr 9, 2002·32 cites·3 claims
- 0987US6166053ASubstituted condensation products of N-benzyl-3-idenylacetamides with heterocyclic aldehydes for neoplasiaCELL PATHWAYS INC·Filed 2000·Granted Dec 26, 2000·14 cites·2 claims
- 1087US5696159ALactone compounds for treating patients with precancerous lesionsCELL PATHWAYS INC·Filed 1994·Granted Dec 9, 1997·35 cites·18 claims
- 1186US6486158B1[4,5]-fused-3,6-disubstituted-pyridazines with sulfur-containing substituents in position three for the treatment of neoplasiaCELL PATHWAYS INC·Filed 2001·Granted Nov 26, 2002·17 cites·33 claims
- 1286US6211177B1Method for treating neoplasia by exposure to substituted 2-aryl-benzimidazole derivativesCELL PATHWAYS INC·Filed 1998·Granted Apr 3, 2001·86 cites·6 claims
- 1383US6420410B1Method for treating neoplasia by exposure to N,N′-substituted benzimidazol-2-onesCELL PATHWAYS INC·Filed 2000·Granted Jul 16, 2002·17 cites·7 claims
- 1483US6177471B1Method for treating patients with acne by administering a CGMP-specific PDE inhibitorCELL PATHWAYS INC·Filed 1999·Granted Jan 23, 2001·66 cites·1 claims
- 1582US6403831B1Substituted benzylidene indenyl formamides, acetamides and propionamidesCELL PATHWAYS INC·Filed 2000·Granted Jun 11, 2002·13 cites·1 claims
- 1682US6180629B1[4,5]-Fused-1,3-disubstituted-1,2-diazine-6-one derivatives with nitrogen containing substitutents in position one for the treatment of neoplasiaCELL PATHWAYS INC·Filed 1998·Granted Jan 30, 2001·28 cites·24 claims
- 1780US6410584B1Method for inhibiting neoplastic cells with indole derivativesCELL PATHWAYS INC·Filed 1998·Granted Jun 25, 2002·46 cites·2 claims
- 1880US5858694AMethod for identifying compounds for inhibition of cancerous lesionsCELL PATHWAYS INC·Filed 1997·Granted Jan 12, 1999·60 cites·26 claims
- 1979US6479493B1Methods for treatment of type I diabetesCELL PATHWAYS INC·Filed 2001·Granted Nov 12, 2002·12 cites·40 claims
- 2079US6300346B1Indenyl hydroxamic acids, (hydroxy) ureas and urethanes for treating patients with precancerous lesionsCELL PATHWAYS INC·Filed 2000·Granted Oct 9, 2001·7 cites·16 claims
- 2178US6262059B1Method of treating a patient having precancerous lesions with quinazoline derivativesCELL PATHWAYS INC·Filed 1998·Granted Jul 17, 2001·44 cites·19 claims
- 2277US6359002B2Method for treating a patient with neoplasia by treatment with a platinum coordination complexCELL PATHWAYS INC·Filed 2001·Granted Mar 19, 2002·4 cites·1 claims
- 2376US5990117AMethod for inhibiting neoplastic cells and related conditions by exposure to quinazoline derivativesCELL PATHWAYS INC·Filed 1998·Granted Nov 23, 1999·43 cites·10 claims
- 2476US5965619AMethod for treating patients having precancerous lesions with substituted indene derivativesCELL PATHWAYS INC·Filed 1997·Granted Oct 12, 1999·47 cites·29 claims
- 2574US6063818ASubstituted benzylidene indenyl formamides, acetamides and propionamidesCELL PATHWAYS INC·Filed 1997·Granted May 16, 2000·32 cites·47 claims
- 2673US6555547B1Method for treating a patient with neoplasia by treatment with a vinca alkaloid derivativeCELL PATHWAYS INC·Filed 2000·Granted Apr 29, 2003·5 cites·17 claims
- 2772US6391885B1Method of treating a patient having precancerous lesions with phenyl cycloamino pyrimidinone derivativesCELL PATHWAYS INC·Filed 2000·Granted May 21, 2002·2 cites·4 claims
- 2871US5948779ASubstituted condensation products of n-benzyl-3-indenyl acetamides with heterocyclic aldehydesCELL PATHWAYS INC·Filed 1997·Granted Sep 7, 1999·13 cites·77 claims
- 2970US6465494B1Methods for treatment of cystic fibrosisCELL PATHWAYS INC·Filed 2001·Granted Oct 15, 2002·5 cites·37 claims
- 3070US6365627B2Method for treating a patient with neoplasia by treatment with a paclitaxel derivativeCELL PATHWAYS INC·Filed 2001·Granted Apr 2, 2002·1 cites·1 claims
- 3170US6066634ASubstituted condensation products of N-benzyl-3-indenylacetamides heterocyclic aldehydes for neoplasiaCELL PATHWAYS INC·Filed 1998·Granted May 23, 2000·12 cites·28 claims
- 3269US6472420B2Method for treating a patient with neoplasia by treatment with a paclitaxel derivativeCELL PATHWAYS INC·Filed 2002·Granted Oct 29, 2002·1 cites·3 claims
- 3368US5874440AMethod of treating a patient having precancerous lesions with phenyl pyrimidinone derivativesCELL PATHWAYS INC·Filed 1995·Granted Feb 23, 1999·27 cites·16 claims
- 3467US6500610B1Methods for identifying compounds for inhibiting of neoplastic lesions, and pharmaceutical compositions containing such compoundsCELL PATHWAYS INC·Filed 1999·Granted Dec 31, 2002·22 cites·12 claims
- 3567US6232312B1Method for treating patient having precancerous lesions with a combination of pyrimidopyrimidine derivatives and esters and amides of substituted indenyl acetic acidesCELL PATHWAYS INC·Filed 1998·Granted May 15, 2001·31 cites·14 claims
- 3666US6071934AIndenyl hydroxamic acids, (hydroxy) ureas and urethanes for treating patients with precancerous lesionsCELL PATHWAYS INC·Filed 1997·Granted Jun 6, 2000·25 cites·4 claims
- 3766US6028116ASubstituted condensation products of 1H-indenyl-hydroxyalkanes with aldehydes for neoplasiaCELL PATHWAYS INC·Filed 1998·Granted Feb 22, 2000·29 cites·52 claims
- 3866US5852035AMethod for inhibiting neoplastic cells and related conditions by exposure to substituted N- arylmethyl and heterocyclmethyl-1H-pyrazolo (3,4-B) quinolin-4-aminesCELL PATHWAYS INC·Filed 1997·Granted Dec 22, 1998·28 cites·15 claims
- 3965US5942520AMethod for inhibiting neoplastic cells by exposure to substituted N-cycloalkylmethyl-1-H-pyrazolo (3,4-B) quinolone-4 aminesCELL PATHWAYS INC·Filed 1998·Granted Aug 24, 1999·27 cites·15 claims
- 4064US6121321ASubstituted methoxy benzylidene indenyl acetic and propionic acids for treating patients with precancerous lesionsCELL PATHWAYS INC·Filed 1996·Granted Sep 19, 2000·26 cites·23 claims
- 4164US5643959AMethod for treating patients with precancerous lesions by administering substituted sulfonyl indenyl acetic and propionic acids and esters thereofCELL PATHWAYS INC·Filed 1994·Granted Jul 1, 1997·17 cites·11 claims
- 4262US6486155B1Method of inhibiting neoplastic cells with isoquinoline derivativesCELL PATHWAYS INC·Filed 1998·Granted Nov 26, 2002·21 cites·2 claims
- 4361US6034099AMethod for inhibiting neoplastic lesions by administering 4-(arylmethylene)- 2, 3- dihydro-pyrazol-3-onesCELL PATHWAYS INC·Filed 1998·Granted Mar 7, 2000·21 cites·9 claims
- 4460US6200771B1Method of using a novel phosphodiesterase in pharmaceutical screeing to identify compounds for treatment of neoplasiaCELL PATHWAYS INC·Filed 1998·Granted Mar 13, 2001·18 cites·13 claims
- 4560US6025394AMethod for treating patients with acne by administering substituted sulfonyl indenyl acetic acids, amides and alcoholsCELL PATHWAYS INC·Filed 1999·Granted Feb 15, 2000·22 cites·9 claims
- 4659US6235776B1Method for treating a patient with neoplasia by treatment with a paclitaxel derivativeCELL PATHWAYS INC·Filed 1998·Granted May 22, 2001·12 cites·10 claims
- 4758US6130053AMethod for selecting compounds for inhibition of neoplastic lesionsCELL PATHWAYS INC·Filed 1999·Granted Oct 10, 2000·20 cites·12 claims
- 4857US6160003A1,3,6-trihydro-6-aza-3-oxapentalen-2-one derivatives for the treatment of neoplasiaCELL PATHWAYS INC·Filed 1999·Granted Dec 12, 2000·5 cites·18 claims
- 4956US6479520B1Method of treating a patient having precancerous lesions with phenyl pyridinone derivativesCELL PATHWAYS INC·Filed 2000·Granted Nov 12, 2002·0 cites·7 claims
- 5056US6046199AMethod of inhibiting neoplastic cells with tetracyclic pyrido[3,4-B]indole derivativesCELL PATHWAYS INC·Filed 1998·Granted Apr 4, 2000·16 cites·12 claims
Showing the top 50 of 73 patent records by PatentIndex Score.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →